These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 23856627)

  • 1. Therapeutic implications of biomarkers in chronic heart failure.
    Ahmad T; O'Connor CM
    Clin Pharmacol Ther; 2013 Oct; 94(4):468-79. PubMed ID: 23856627
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The role of natriuretic peptides as biomarkers for guiding the management of chronic heart failure.
    Motiwala SR; Januzzi JL
    Clin Pharmacol Ther; 2013 Jan; 93(1):57-67. PubMed ID: 23187878
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Novel biomarkers in chronic heart failure.
    Ahmad T; Fiuzat M; Felker GM; O'Connor C
    Nat Rev Cardiol; 2012 Mar; 9(6):347-59. PubMed ID: 22450126
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Old and new biomarkers of heart failure.
    Emdin M; Vittorini S; Passino C; Clerico A
    Eur J Heart Fail; 2009 Apr; 11(4):331-5. PubMed ID: 19329823
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Biomarker-guided treatment of heart failure: still waiting for a definitive answer.
    Troughton RW; Frampton CM; Nicholls MG
    J Am Coll Cardiol; 2010 Dec; 56(25):2101-4. PubMed ID: 21144970
    [No Abstract]   [Full Text] [Related]  

  • 6. [ANMCO/ELAS/SIBioC Consensus document: Recommendations for the use of cardiac biomarkers in heart failure patients].
    Aspromonte N; Gulizia MM; Clerico A; Di Tano G; Emdin M; Feola M; Iacoviello M; Latini R; Mortara A; Valle R; Misuraca G; Passino C; Masson S; Aimo A; Ciaccio M; Migliardi M
    G Ital Cardiol (Rome); 2016 Sep; 17(9):615-656. PubMed ID: 27869886
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evolution of natriuretic peptide biomarkers in heart failure: Implications for clinical care and clinical trials.
    Vodovar N; Mebazaa A; Januzzi JL; Murtagh G; Stough WG; Adams KF; Zannad F
    Int J Cardiol; 2018 Mar; 254():215-221. PubMed ID: 29407093
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The potential role of natriuretic peptide-guided management for patients hospitalized for heart failure.
    Maisel A; Xue Y; Greene SJ; Pang PS; Januzzi JL; Piña IL; DeFilippi C; Butler J
    J Card Fail; 2015 Mar; 21(3):233-9. PubMed ID: 25433362
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Current and Potential Clinical Relevance of Heart Failure Biomarkers.
    Gandhi PU; Testani JM; Ahmad T
    Curr Heart Fail Rep; 2015 Oct; 12(5):318-27. PubMed ID: 26280466
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Role of biomarkers for risk stratification in the tailored follow-up of heart failure patients].
    Aspromonte N; Di Tano G; Latini R; Masson S; Valle R; Emdin M
    G Ital Cardiol (Rome); 2010 May; 11(5 Suppl 2):17S-23S. PubMed ID: 20873464
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Use of biomarkers to guide outpatient therapy of heart failure.
    DeBeradinis B; Januzzi JL
    Curr Opin Cardiol; 2012 Nov; 27(6):661-8. PubMed ID: 22941124
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Management of chronic heart failure guided by individual N-terminal pro-B-type natriuretic peptide targets: results of the PRIMA (Can PRo-brain-natriuretic peptide guided therapy of chronic heart failure IMprove heart fAilure morbidity and mortality?) study.
    Eurlings LW; van Pol PE; Kok WE; van Wijk S; Lodewijks-van der Bolt C; Balk AH; Lok DJ; Crijns HJ; van Kraaij DJ; de Jonge N; Meeder JG; Prins M; Pinto YM
    J Am Coll Cardiol; 2010 Dec; 56(25):2090-100. PubMed ID: 21144969
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Will the therapy of chronic heart failure be guided by plasma levels of natriuretic peptides?].
    Hradec J; Krupicka J; Janota T
    Cas Lek Cesk; 2009; 148(8):383-8. PubMed ID: 19899725
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Biomarker-guided therapy in chronic heart failure: a meta-analysis of randomized controlled trials.
    Felker GM; Hasselblad V; Hernandez AF; O'Connor CM
    Am Heart J; 2009 Sep; 158(3):422-30. PubMed ID: 19699866
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Biomarkers in heart failure: an update].
    Emdin M; Barison A; Passino C; Vergaro G
    G Ital Cardiol (Rome); 2013 Dec; 14(12):809-16. PubMed ID: 24336596
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Biomarkers in heart failure: BNP and NT-proBNP].
    Ho CC; Liu CC
    Hu Li Za Zhi; 2009 Oct; 56(5):16-22. PubMed ID: 19760573
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Biomarkers for chronic heart failure : diagnostic, prognostic, and therapeutic challenges.
    Lainscak M; Anker MS; von Haehling S; Anker SD
    Herz; 2009 Dec; 34(8):589-93. PubMed ID: 20024637
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Q: Should target natriuretic peptide levels be used for outpatient management of chronic heart failure?
    Ibrahim A; Baibars M; Alraies MC; Oliveira GH
    Cleve Clin J Med; 2012 Jan; 79(1):22-5. PubMed ID: 22219230
    [No Abstract]   [Full Text] [Related]  

  • 19. Design and methods of the Pro-B Type Natriuretic Peptide Outpatient Tailored Chronic Heart Failure Therapy (PROTECT) Study.
    Bhardwaj A; Rehman SU; Mohammed A; Baggish AL; Moore SA; Januzzi JL
    Am Heart J; 2010 Apr; 159(4):532-538.e1. PubMed ID: 20362709
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Drug and device effects on peak oxygen consumption, 6-minute walk distance, and natriuretic peptides as predictors of therapeutic effects on mortality in patients with heart failure and reduced ejection fraction.
    Wessler BS; Kramer DG; Kelly JL; Trikalinos TA; Kent DM; Konstam MA; Udelson JE
    Circ Heart Fail; 2011 Sep; 4(5):578-88. PubMed ID: 21705485
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.